|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's range||39.77 - 39.77|
|52-week range||31.55 - 49.86|
|Beta (5Y monthly)||0.97|
|PE ratio (TTM)||23.53|
|Forward dividend & yield||1.21 (3.05%)|
|Ex-dividend date||17 May 2023|
|1y target est||N/A|
What trends should we look for it we want to identify stocks that can multiply in value over the long term? One common...
Fresenius Medical (FMS) wins legal dispute against the U.S. government. Both revenues and operating income will benefit from the settlement agreement.
Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.